Status:
COMPLETED
Dosage of Serum Tryptase Levels in a Population of Premature Newborns to Evaluate Mast Cell Activity
Lead Sponsor:
CHU de Reims
Conditions:
Premature Newborns
Eligibility:
All Genders
Up to 1 years
Phase:
NA
Brief Summary
Compare serum tryptase levels of premature babies (\<37 weeks of amenorrhea) to children born at full term. Study the evolution of serum tryptase levels in premature babies(\<37 weeks of amenorrhea)....
Detailed Description
It seems appropriate to believe that prematurity associated or not with a genetic-related sensitivity, involving several signaling pathways, makes children more vulnerable to different environmental, ...
Eligibility Criteria
Inclusion
- Inclusion Criteria "Patients" :
- all premature babies (\<37 weeks of amenorrhea)
- managed in the first 24 hours of life at the Reims university hospital
- parents accepted to participate in the research - social security card
- Inclusion Criteria "Controls" :
- children born full term, just after each "patient" child included
- managed in the first 24 hours of life at the Reims university hospital
- parents accepted to participate in the research.
- Exclusion Criteria "Patients" and "Controls"
- Not managed in the first 24 hours of life at the Reims University Hospital,
- Person, who has parental authority, protected by law,
- Newborns with a life and death emergency in the first 24 h of life,
- Person, who has parental authority, under age 18
Exclusion
Key Trial Info
Start Date :
October 12 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
87 Patients enrolled
Trial Details
Trial ID
NCT02787980
Start Date
October 12 2015
End Date
December 31 2019
Last Update
April 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Reims
Reims, France, 51092